Stoke Therapeutics' Chief Medical Officer Sold Over 5,000 Shares in the Company. Should Shareholders Sell?
Key PointsBarry Ticho, Chief Medical Officer of Stoke Therapeutics, sold 5,358 shares for a transaction value of $167,115.04 at a weighted average price of $31.19 per share in December...
Nasdaq News: Markets·6d ago